𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer

✍ Scribed by Luis A. Solé; Joan Albanell; Joaquim Bellmunt; Antonio Ribas; Oscar S. Gallego; Joan Carulla

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
500 KB
Volume
75
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical activity of cisplatin and prolo
Clinical activity of cisplatin and prolonged oral administration of etoposide in previously treated, anthracycline-resistant, metastatic breast cancer patients: A phase II study
✍ Fried, Getta; Stein, Moshe E.; Haim, Nissim 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 2 views

Background. This phase II study evaluates the antitumor activity and tolerance of cisplatin and prolonged oral administration of etoposide in metastatic breast cancer previously exposed to anthracyclines. Procedure. Twenty-seven patients with metastatic breast cancer who developed tumor progression

A phase II trial of oral tegafur and ura
A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer
✍ Yukito Ichinose; Nobuko Takanashi; Tokujiro Yano; Hiroshi Asoh; Hideki Yokoyama; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 2 views

## Background: The combination of uracil and tegafur in a 4:1 molar concentration (uft) has a greater antitumor activity than 5-fluorouracil (5-fu) and tegafur. because the combination of 5-fu and cisplatin has been proven to have a synergistic antitumor effect in many experimental and clinical stu